Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CheongKwanJang is the world's leading brand of Korean Red Ginseng, managed by the Korea Ginseng Corporation (KGC). With a heritage dating back to 1899, the company specializes in the cultivation, processing, and distribution of premium six-year-grown red ginseng products. Their portfolio includes high-potency extracts, tonics, and functional health supplements designed to boost immunity, improve blood circulation, and enhance cognitive function. The company maintains rigorous quality control through its R&D center, which is one of the largest ginseng research facilities globally, focusing on the pharmacological effects of ginsenosides. CheongKwanJang operates an extensive international retail network and is recognized as a global leader in the herbal health supplement and traditional medicine markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CheongKwanJang.